Back to the main directory
EarningsReview / Equity
- Elekta - Another solid print to record by Danske Bank Equity Research
- Luk Fook (590 HK) by HSBC
- H121 sales and 15 questions for management by BNP Paribas Exane
- Elekta (Buy, TP: SEK125.00) - New CEO, and Covid-19 impact by DnB Markets
- Hunter Group Minor model adjustments by DnB Markets
- The Low Carb(on) Diet by BNP Paribas Exane
- Elekta - Buy/SEK 165: Strong Q2 earnings growth with good cost control by Nordea
- Hunter Group - Buy/NOK 4.30 (4.50): Dividend on the agenda by Nordea
- Delay will repay by BNP Paribas Exane
- EU taxonomy tinkering by BNP Paribas Exane
- WOOD Flash – CA Immo: 3Q20 – FFO on track, portfolio rotation continuing, moving to renewable energy by Wood and Company
- Investment Daily 27/11/2020 by BNP Paribas Exane
- INVEST SECURITIES - WORLDLINE : Peu de catalyseurs CT, mais leviers MT intacts - ACHAT, OC 95€ (vs 84€) by Invest Securities
- INVEST SECURITIES - INDITEX : Belle envolée en dépit du second confinement - ACHAT, OC 33,3€ (vs 31,8€) by Invest Securities
- Aier Eye Hospital Group (300015 CH) by HSBC
- Café de Coral (341 HK) by HSBC
- Good quarter, but still cautious on guidance by BNP Paribas Exane
- Sats (Hold, TP: NOK18.00) - Club closures slightly up by DnB Markets
- Seafood - Fat Trout Weekly by DnB Markets
- Weekly news, topics & discussions by DnB Markets
- Pihlajalinna - Long-term challenged but recovery in 2021 by Danske Bank Equity Research
- Tender offers and initiation of coverage by DnB Markets
- China Gas Holdings (384 HK) by HSBC
- When a plan comes together by BNP Paribas Exane
- Animal spirits or liquidity trap? by BNP Paribas Exane
- Medistim - Go with the flow by Danske Bank Equity Research
- Odfjell Drilling - Remains on pathway to dividends by Danske Bank Equity Research
- Frontline (Hold, TP: NOK65.00) - Going to the mattresses by DnB Markets
- Nyfosa (Buy, TP: SEK93.00) - M&A in the DNA by DnB Markets
- Westports Holdings Berhad (WPRTS MK) by HSBC
- Volkswagen exits the Key Ideas list by BNP Paribas Exane
- Growth on the ''Horizon'' by BNP Paribas Exane
- Margin call by BNP Paribas Exane
- Going MONTEneering? by BNP Paribas Exane
- 4Q20 Preview: Baking in Lockdown 2.0 by BNP Paribas Exane
- The Low Carb(on) Diet by BNP Paribas Exane
- INVEST SECURITIES - ALTEN : Ne pas mettre la charrue avant les bœufs - NEUTRE vs ACHAT, OC 95€ (vs 97€) by Invest Securities
- INVEST SECURITIES - FONCIERE ATLAND : En croissance malgré la pandémie - ACHAT vs SOUS REVUE, OC 36,8€ (vs SOUS REVUE) by Invest Securities
- Virgin Money (VMUK LN) by HSBC
- 爱尔眼科（300015 CH） by HSBC
- WOOD Flash – Bank of Cyprus: 3Q20 in line, realistic medium-term targets by Wood and Company
- Rejected bid on CXM offers support to the shares by BNP Paribas Exane
- Asarina Pharma (No_rec, TP: SEK) - Discontinuing coverage by DnB Markets
- Valuation update: Implied oil price of USD50–67/bbl for Nordic E&Ps by DnB Markets
- The weekly navigator by DnB Markets
- Volvo (Buy, TP: SEK230.00) - Continuing to ramp up by DnB Markets
- Union Medical Healthcare (2138 HK) by HSBC
- $185,000,000,000,000 reasons why by BNP Paribas Exane
- Right on the money by BNP Paribas Exane
- Nanoform - Major progress, again by Danske Bank Equity Research